STEPAN director granted 2,566 SCL shares
Burgess Lorinda reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Burgess Lorinda reported acquisition or exercise transactions in this Form 4 filing.
STEPAN CO director Lorinda Burgess received a grant of 2,566 shares of Common Stock on May 8, 2026. The award was recorded at a price of $52.61 per share, reflecting compensation rather than an open-market purchase. Following this grant, she directly holds 5,900 Common Stock shares in total.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 2,566 | $52.61 | $135K |
Key Figures
Key Terms
Common Stock financial
Grant, award, or other acquisition financial
Form 4 regulatory
direct ownership financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did STEPAN CO (SCL) director Lorinda Burgess report in this Form 4?
Was the Lorinda Burgess Form 4 transaction in SCL an open-market buy or a grant?
Does the Lorinda Burgess Form 4 show any sales of STEPAN CO (SCL) stock?
AI-generated analysis. How Rhea-AI works. Not financial advice.